Ribostamycin
From Wikipedia, the free encyclopedia
Systematic (IUPAC) name | |
---|---|
(1R,2R,3S,4R,6S)-4,6-diamino-3-hydroxy-2-(β-D-ribofuranosyloxy)cyclohexyl 2,6-diamino-2,6-dideoxy-α-D-glucopyranoside | |
Clinical data | |
AHFS/Drugs.com | International Drug Names |
Legal status | ? |
Identifiers | |
CAS number | 53797-35-6 |
ATC code | J01GB10 |
PubChem | CID 5066 |
UNII | 2Q5JOU7T53 |
ChEMBL | CHEMBL1256830 |
Synonyms | (2R,3S,4R,5R,6R)-5-amino-2-(aminomethyl)-6-{[(1R,2R,3S,4R,6S)-4,6-diamino-2-{[(2S,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy}-3-hydroxycyclohexyl]oxy}oxane-3,4-diol |
Chemical data | |
Formula | C17H34N4O10 |
Mol. mass | 454.47266 g/mol |
(what is this?) (verify) | |
Ribostamycin (INN) is an aminoglycoside antibiotic.
|
This article is issued from Wikipedia. The text is available under the Creative Commons Attribution/Share Alike; additional terms may apply for the media files.